Abstract:Gadolinium-based magnetic resonance imaging (MRI) contrast agents with biodegradability, biosafety, and high efficiency are highly desirable for tumor diagnosis. Herein, a biodegradable, AS1411-conjugated, α-cyclodextrin polyrotaxane-based MRI contrast agent (AS1411-G2(DTPA-Gd)-SS-PR) was developed for targeted imaging of cancer. The polyrotaxane-based contrast agent was achieved by the complexation of α-cyclodextrin (α-CD) and a linear poly(ethylene glycol) (PEG) chain containing disulfide linkages at two terminals. The disulfides enable the dethreading of the polyrotaxane into excretable small units due to cleavage of the disulfide linkages by reducing agents such as intracellular glutathione (GSH). Furthermore, the second-generation lysine dendron conjugated with gadolinium chelates and AS1411, a G-quadruplex oligonucleotide that has high binding affinity to nucleolin generally presenting a high level on the surface of tumor cells, coupled to the α-CD via click chemistry. The longitudinal relaxivity of AS1411-G2(DTPA-Gd)-SS-PR (11.7 mM-1 s-1) was two times higher than the clinically used Gd-DTPA (4.16 mM-1 s-1) at 0.5 T. The in vitro degradability was confirmed by incubating with 10 mM 1,4-dithiothreitol (DTT). Additionally, the cytotoxicity, histological assessment, and gadolinium retention studies showed that the prepared polyrotaxane-based contrast agent had a superior biocompatibility and was predominantly cleared renally without long-term accumulation toxicity. Importantly, AS1411-G2(DTPA-Gd)-SS-PR displayed the enhanced performance in MRI of breast cancer cells in vitro as well as a subcutaneous breast tumor in vivo due to the targeting ability of the AS1411 aptamer. The enhanced performance was due to efficient multivalent interactions with tumor cells, producing faster accumulation and longer contrast imaging time at the tumor site. This work clearly confirms that the specially designed and fabricated α-CD-based polyrotaxane is a promising contrast agent with an excellent contrast imaging performance and biosafety for tumor MR imaging.

A branched polymer-based agent for efficient and precise targeting of fibrosis diseases by magnetic resonance imaging

Stimuli-Responsive Biodegradable Hyperbranched Polymer–Gadolinium Conjugates as Efficient and Biocompatible Nanoscale Magnetic Resonance Imaging Contrast Agents

Multi-arm star-branched polymer as an efficient contrast agent for tumor-targeted magnetic resonance imaging

Tumor Environment-Responsive Degradable Branched Glycopolymer Magnetic Resonance Imaging Contrast Agent and Its Tumor-Targeted Imaging.

Functional Hyperbranched Polylysine As Potential Contrast Agent Probes for Magnetic Resonance Imaging

Preparation and performance of biocompatible gadolinium polymer as liver-targeting magnetic resonance imaging contrast agent

Stimuli-responsive Biodegradable and Gadolinium-Based Poly[n-(2-hydroxypropyl) Methacrylamide] Copolymers: Their Potential As Targeting and Safe Magnetic Resonance Imaging Probes

A neutral polydisulfide containing Gd(III) DOTA monoamide as a redox‐sensitive biodegradable macromolecular MRI contrast agent

A Targeted Nanoglobular Contrast Agent from Host-Guest Self-Assembly for MR Cancer Molecular Imaging.

Peptide-Based Soft Hydrogels Modified with Gadolinium Complexes as MRI Contrast Agents

High relaxivity Gd3+-based organic nanoparticles for efficient magnetic resonance angiography

Amphiphilic block polymer-gadolinium conjugates: Design, synthesis and application as efficient and safe nanoscale magnetic resonance imaging contrast agents

Non-invasive diagnosis of liver fibrosis via MRI using targeted gadolinium-based nanoparticles

Gadolinium(III) Chelated Conjugated Polymer As a Potential MRI Contrast Agent

Development of an Aptamer-Conjugated Polyrotaxane-Based Biodegradable Magnetic Resonance Contrast Agent for Tumor-Targeted Imaging.

Preparation of MRI-visible Gadolinium Methacrylate Nanoparticles with Low Cytotoxicity and High Magnetic Relaxivity

Gadolinium (III)-Chelated Deformable Mesoporous Organosilica Nanoparticles as Magnetic Resonance Imaging Contrast Agent.

Geometrical Confinement of Gadolinium Oxide Nanoparticles in Poly(ethylene Glycol)/arginylglycylaspartic Acid-Modified Mesoporous Carbon Nanospheres As an Enhanced T1 Magnetic Resonance Imaging Contrast Agent.

Biodegradable Nanoglobular Magnetic Resonance Imaging Contrast Agent Constructed with Host-Guest Self-Assembly for Tumor-Targeted Imaging.

Long-Lasting and Efficient Tumor Imaging Using a High Relaxivity Polysaccharide Nanogel Magnetic Resonance Imaging Contrast Agent

Targeted Biodegradable Dendritic MRI Contrast Agent for Enhanced Tumor Imaging